Rapid and Highly Sensitive Detection of Fluorescently-labeled Troponin in Patients Admitted With Chest Pain

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02897492

Enrollment

100

Registered

2016-09-13

Start date

2016-09-01

Completion date

2019-03-20

Last updated

2019-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain

Brief summary

Patients with chest pain may have postponed or missed diagnosis of acute coronary events due to relatively late detection of troponin elevation. The study will investigate a new diagnostic method for early detection of even minimal troponin elevation in patients admitted with chest pain.

Detailed description

Interventions

OTHERBlood testing in a newly described method

To exploit detection strategy termed Magnetic Modulation Biosensing, or MMB) to develop a novel, low-cost platform that can detect biomarkers, such as proteins and specific DNA sequences, rapidly and directly from real samples at very low concentrations.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 120 Years

Healthy volunteers

Yes

Inclusion criteria

1. Patients 18 years old or older 2. Admitted to Rambam health campus for the investigation of chest pain

Exclusion criteria

1\. No

Design outcomes

Primary

Measure	Time frame
Time to detect troponin elevation	sixty to 120 minutes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026